Bristol-Myers Eliquis battles; Indian FRAND rate setting; IAM Global Leaders; Lenovo sues Asus; historic CRISPR drug approval; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.

MONDAY 13 November

Event coverage: Trade secrets, injunctions and AI – the IAM-WTR Latin America IP Summit

FTC challenges 100 patent listings, tightening screws on pharma companies

Data dive: These law firms top the rankings for US patent litigation

Trade secrets: Toy maker sues rival for “brazen” trade secrets theft

TUESDAY 14 November

Chinese patent office hands down key ruling on pharma patent requirements

Bristol-Myers fighting intense battle to keep Eliquis generics off European markets

WEDNESDAY 15 November

Micron targeted by Chinese semiconductor firm in US litigation

Trade secrets: Samsung Display faces off with China’s BOE in ITC trade secrets spat

Weekly column: The EU should listen to its Nordic champions, not ignore them

THURSDAY 16 November

Indian court opens up option for global FRAND rate setting in Nokia-Oppo dispute

Regeneron asserts swathe of patents in latest Eylea biosimilar clash

IAM Global Leaders: AI can super-charge private practice work – but experts warn that there are still considerable risks

Policy: US policymakers wading through stakeholder feedback on patents and technology standards

FRIDAY 17 November

Lenovo sues Asus amid surge of US patent litigation triggered by Chinese companies

Historic CRISPR drug approval heralds new era in Cas9 IP wars

Data dive: Qualcomm leads Brazilian patent filings this year

SATURDAY 18 November

Opinion: IP disclosure requirements are changing – and that is a good thing

Unlock unlimited access to all IAM content